Tarbox Family Office, Inc. Gilead Sciences, Inc. Transaction History

Tarbox Family Office, Inc.

$609 Million
Q3 2024

A detailed history of Tarbox Family Office, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tarbox Family Office, Inc. holds 3,274 shares of GILD stock, worth $309,098. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,274

Previous 3,304 0.91%

Holding current value

$309,098

Previous $226,000 21.24%

% of portfolio

0.05%

Previous 0.04%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$66.59 - $83.99 $1,997 - $2,519	-30 Reduced 0.91%	3,274 $274,000
Q2 2024 Jul 16, 2024	SELL	$63.15 - $72.88 $1,768 - $2,040	-28 Reduced 0.84%	3,304 $226,000
Q1 2024 Apr 15, 2024	SELL	$71.58 - $87.29 $1,288 - $1,571	-18 Reduced 0.54%	3,332 $244,000
Q4 2023 Feb 08, 2024	BUY	$73.27 - $83.09 $73 - $83	1 Added 0.03%	3,350 $271,000
Q3 2023 Oct 13, 2023	SELL	$73.94 - $80.67 $369 - $403	-5 Reduced 0.15%	3,349 $250,000
Q2 2023 Jul 20, 2023	BUY	$76.01 - $86.7 $1,520 - $1,734	20 Added 0.6%	3,354 $258,000
Q1 2023 Apr 11, 2023	SELL	$77.31 - $88.08 $246,541 - $280,887	-3,189 Reduced 48.89%	3,334 $276,000
Q4 2022 Jan 25, 2023	BUY	$62.32 - $89.47 $2,181 - $3,131	35 Added 0.54%	6,523 $0
Q2 2022 Jul 19, 2022	SELL	$57.72 - $65.01 $1,327 - $1,495	-23 Reduced 0.35%	6,488 $401,000
Q1 2022 Apr 25, 2022	SELL	$57.92 - $72.58 $14,769 - $18,507	-255 Reduced 3.77%	6,511 $387,000
Q4 2021 Jan 06, 2022	BUY	$64.88 - $73.64 $1,946 - $2,209	30 Added 0.45%	6,766 $491,000
Q3 2021 Oct 12, 2021	BUY	$67.69 - $73.03 $270 - $292	4 Added 0.06%	6,736 $471,000
Q4 2020 Jan 27, 2021	SELL	$56.65 - $64.55 $4,192 - $4,776	-74 Reduced 1.09%	6,732 $392,000
Q3 2020 Oct 22, 2020	SELL	$62.1 - $78.08 $2,297 - $2,888	-37 Reduced 0.54%	6,806 $430,000
Q2 2020 Jul 23, 2020	SELL	$72.34 - $84.0 $795 - $924	-11 Reduced 0.16%	6,843 $527,000
Q1 2020 Apr 30, 2020	BUY	$62.63 - $80.22 $16,409 - $21,017	262 Added 3.97%	6,854 $512,000
Q4 2019 Jan 31, 2020	SELL	$61.62 - $67.78 $1,109 - $1,220	-18 Reduced 0.27%	6,592 $428,000
Q3 2019 Oct 25, 2019	BUY	$62.51 - $69.0 $500 - $552	8 Added 0.12%	6,610 $419,000
Q2 2019 Aug 02, 2019	BUY	$61.87 - $69.38 $5,320 - $5,966	86 Added 1.32%	6,602 $446,000
Q1 2019 Apr 24, 2019	BUY	$62.53 - $70.05 $5,377 - $6,024	86 Added 1.34%	6,516 $424,000
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $8,415 - $10,981	-139 Reduced 2.12%	6,430 $402,000
Q3 2018 Oct 29, 2018	SELL	$71.28 - $78.92 $784 - $868	-11 Reduced 0.17%	6,569 $507,000
Q2 2018 Jul 31, 2018	BUY	$64.88 - $75.68 $64 - $75	1 Added 0.02%	6,580 $466,000
Q1 2018 Apr 25, 2018	BUY	$72.84 - $88.8 $1,821 - $2,220	25 Added 0.38%	6,579 $496,000
Q4 2017 Jan 29, 2018	SELL	$71.15 - $83.52 $355 - $417	-5 Reduced 0.08%	6,554 $470,000
Q3 2017 Oct 19, 2017	BUY	$72.11 - $85.47 $472,969 - $560,597	6,559	6,559 $531,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tarbox Family Office, Inc. with notifications on news.

Account

Tarbox Family Office, Inc. Gilead Sciences, Inc. Transaction History